Medicare Enrolled

Dr. Peter Ruff, MD

Urology Physician · Austin, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
608 RADAM LN, Austin, TX 78745
5124435988
In practice since 2005 (20 years)
NPI: 1487646790 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ruff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ruff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ruff

Dr. Peter Ruff is an urology physician in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ruff performed 5,693 Medicare services across 1,615 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ruff received a total of $146,747 from 36 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ruff is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 20% volume in TX $146,747 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,693
Medicare services
Top 20% in TX for urology physician
1,615
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~285 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based) 3,000 $0 $1
Chronic care management, first 20 min/month 744 $46 $77
Office visit, established patient (30-39 min) 484 $86 $249
Automated urinalysis 390 $2 $7
Chronic care management, additional 20 min/month 293 $36 $77
Blood draw (venipuncture) 177 $8 $15
Bladder ultrasound after voiding 100 $8 $44
Office visit, established patient (20-29 min) 89 $60 $168
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month 66 $42 $82
Office visit, established patient, complex (40-54 min) 62 $138 $336
New patient office visit (45-59 min) 51 $125 $380
Diagnostic exam of bladder and urethra using an endoscope 37 $193 $477
Blood creatinine level 28 $5 $16
Removal of lymph nodes of both sides of pelvis using an endoscope 24 $257 $1,864
Surgical removal of prostate and surrounding lymph nodes using an endoscope 24 $919 $4,047
Ct scan of abdomen and pelvis before and after contrast 24 $218 $745
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope 20 $578 $1,974
Complete ultrasound scan behind abdominal cavity 15 $61 $248
Electronic assessment of bladder emptying 14 $4 $116
Insertion of stent in ureter using an endoscope 14 $88 $1,145
Ct scan of abdomen and pelvis without contrast 13 $91 $419
Ultrasound scan of pelvic region through rectum 13 $116 $250
Biopsy of prostate gland 11 $184 $508
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
55.8% medium
44.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$146,747
Total received (2018-2024)
Avg $20,964/year across 7 years
Top 4% in TX for urology physician
36
Companies
304
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$142,627 (97.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,120 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$64,036
2023
$12,498
2022
$21,601
2021
$22,401
2020
$9,238
2019
$16,622
2018
$351

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$79,182
INTUITIVE SURGICAL, INC.
$63,403
NeoTract Inc.
$1,420
AbbVie Inc.
$539
ABBVIE INC.
$445
PFIZER INC.
$294
Astellas Pharma US Inc
$222
AbbVie, Inc.
$188
PROCEPT BioRobotics Corporation
$95
Dornier MedTech America, Inc
$94
Myovant Sciences Inc.
$80
Becton, Dickinson and Company
$80
Olympus America Inc.
$64
Dendreon Pharmaceuticals LLC
$62
Sumitomo Pharma America, Inc.
$62
Innovation Technologies Inc
$49
Boston Scientific Corporation
$45
Blue Earth Diagnostics Limited
$45
Endo Pharmaceuticals Inc.
$40
UROVANT SCIENCES INC
$33
TELA Bio, Inc.
$31
Progenics Pharmaceuticals, Inc.
$27
Rochester Medical Corporation
$23
TOLMAR Pharmaceuticals, Inc.
$22
Merck Sharp & Dohme Corporation
$21
Pacira Pharmaceuticals Incorporated
$20
Travere Therapeutics, Inc.
$20
Janssen Biotech, Inc.
$19
Avadel Specialty Pharmaceuticals, LLC
$18
Ferring Pharmaceuticals Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Abbott Laboratories
$15
Ambu Inc.
$14
Allergan Inc.
$14
UROGEN PHARMA, INC.
$13
Antares Pharma, Inc.
$12
Top 3 companies account for 98.1% of total payments
Associated products mentioned in payments ›
(815) Thiola · AMS 700 · AQUABEAM SYSTEM · ARISTA AH FLEXITIP · AdVance XP · Androgel · Axumin · BOTOX · Da Vinci Surgical System · ELIGARD · EXPAREL · GEMTESA · IRRISEPT · JELMYTO · LUPRON DEPOT · Lithotripters & Accessories · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PROCLAIM · PROVENGE · PYLARIFY · TOVIAZ · UROLIFT · UroLift · XIAFLEX · XTANDI · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for urology physician in TX.

Equivalent to $2,578 per 100 Medicare services performed
Looking for an urology physician in Austin?
Compare urology physicians in the Austin area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
63
Per 100K population
4.8
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ruff is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), with speaking/promotional industry engagement in the top 4% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ruff experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ruff performed 3,000 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ruff receive payments from pharmaceutical companies?
Yes. Dr. Ruff received a total of $146,747 from 36 companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ruff's costs compare to other urology physicians in Austin?
Dr. Ruff's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ruff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →